Key result
The recently introduced POLARx cryoballoon technology appears to have similar efficacy and safety as the Arctic Front Advance Pro for the treatment of symptomatic atrial fibrillation.
Why the study?
Does a novel integrated dilator and needle optimize the transseptal procedural workflow during cryoballoon ablation in patients with symptomatic atrial fibrillation?
Does a novel integrated dilator and needle optimize the transseptal procedural workflow during cryoballoon ablation in patients with symptomatic atrial fibrillation?
A novel integrated dilator and needle is introduced to optimize the transseptal procedural workflow during cryoballoon ablation.
No takes yet. Share an insight, caveat, or question.
Broadens cryoballoon options for symptomatic AF ablation; provides first randomized comparison of POLARx versus Arctic Front.
Yap et al. (2021) studied symptomatic atrial fibrillation. POLARx cryoballoon technology vs. Arctic Front Advance Pro was evaluated. The recently introduced POLARx cryoballoon technology appears to have similar efficacy and safety as the Arctic Front Advance Pro for the treatment of symptomatic atrial fibrillation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: